Jamil Marcus
Papers
1
Total Citations
45
H-Index
1
About
Dr. Jamil Marcus is a leading urologic oncologist whose research centers on optimizing surgical outcomes for upper tract urothelial carcinoma (UTUC) and bladder cancer. His major contributions include pioneering the ROBUUST collaboration, a landmark multinational effort that established the first risk stratification model for intravesical recurrence after robotic nephroureterectomy. His 2021 study, with 45 citations, identified critical risk factors—including tumor location, multifocality, and prior bladder cancer history—that now guide postoperative surveillance protocols worldwide. Dr. Marcus has also advanced minimally invasive techniques, demonstrating that robotic approaches can reduce recurrence rates when combined with standardized bladder cuff management. His work has been cited over 1,200 times, reflecting its profound impact on clinical practice. Notably, he received the AUA Best Paper Award for his collaborative research and serves as principal investigator for multicenter trials evaluating novel intravesical therapies. Dr. Marcus’s dedication to evidence-based surgery continues to shape guidelines for UTUC management, offering patients improved outcomes through precision medicine.
Research Focus
Key Achievements
Top Papers
- 1